Century Therapeutics IPSC
NASDAQ IPSC
$1.65 -0.02 (-1.20%)
At close: Sep 29, 2026 · 4:00 PM EDT

Century Therapeutics (IPSC) EV to CFO (2022)

Updated

Century Therapeutics' (IPSC) EV to CFO stood at -1.11 in Q4 2022.

Analysis

Century Therapeutics (IPSC) EV to CFO (2022) Analysis & Trends

Starting with Q1 2022, Century Therapeutics' EV to CFO history includes 4 quarters.

  • Per Business Quant, the preceding three quarters came in at 17.42 (Q3 2022), 8.16 (Q2 2022) and 18.26 (Q1 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Century Therapeutics 301.51 Mn -202.86 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 -1.11
Sep 30, 2022 17.42
Jun 30, 2022 8.16
Mar 31, 2022 18.26
API Access

Century Therapeutics EV to CFO API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=IPSC&period=max&api_key=YOUR_API_KEY